iBio IBIO
NASDAQ IBIO
$1.18 +0.01 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

iBio (IBIO) Other financing activities (2025)

Updated

iBio's Other financing activities was $50.01 million in fiscal Q1 2026 (quarter ended Sep 30, 2025).

Analysis

iBio (IBIO) Other financing activities (2025) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Other financing activities at iBio came in at $6.25 million.

  • Other financing activities shows a three-year compound annual growth rate of 399.9% (FY2022 to FY2025).
  • In earlier fiscal years, Other financing activities was $50,000 in FY2022.
  • The fiscal Q1 2026 figure marks the lowest quarterly Other financing activities since fiscal Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 iBio 122.79 Mn 122.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 50.01 Mn
API Access

iBio Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IBIO&period=max&api_key=YOUR_API_KEY